Streamlined access to authentic, FDA-approved, rigorously-tested Zepbound comes from Sesame’s direct integration with Gifthealth. Zepbound is the first and only FDA-approved dual glucagon-like peptide ...

Obesity affects approximately 100 million Indian adults and is linked to over 200 health complications, including heart ...

Eli Lilly launched its weight loss drug Mounjaro in India. According to the company, the injection is supposed to be taken ...

Mounjaro, a new treatment for Type 2 diabetes and obesity, has been launched in India after CDSCO approval. The drug, ...

Global pharmaceutical company Eli Lilly and Company (India) has introduced Mounjaro (tirzepatide) in India, a breakthrough ...

Eli Lilly has launched Mounjaro in India, a new once-weekly injectable drug for type 2 diabetes and weight management.

The drug will be priced at ₹3,500 for a 2.5 mg vial and ₹4,375 for the 5 mg vial. The injectable, to be taken once a week, ...

which is available in single-dose vials, priced at Rs3,500 for a 2.5 mg vial and Rs4,375 for a 5 mg vial. Depending on the dosage, monthly costs range from Rs14,000 to Rs17,500. Mounjaro is the first ...

When administered once per week, Ozempic enhances insulin production in response to high blood sugar levels, leading to better glucose management. It helps slow digestion, reduce the release of ...

These medications are glucose-dependent insulinotropic polypeptide (GIP) receptors and GLP-1 receptor agonists. In 2024, the FDA approved Zepbound (tirzepatide) for the treatment of moderate to severe ...